share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 26 11:16
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 354 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $150,697.80, were acquired on 02/24/2024 through restricted stock vesting and performance shares as part of compensation from the issuer. This transaction follows a series of sales over the past three months, where Tatsis sold a total of 1,154 shares for gross proceeds of $485,771.76.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 354 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $150,697.80, were acquired on 02/24/2024 through restricted stock vesting and performance shares as part of compensation from the issuer. This transaction follows a series of sales over the past three months, where Tatsis sold a total of 1,154 shares for gross proceeds of $485,771.76.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more